Chandra Ayurved Bhawan Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 26-07-2024
- Paid Up Capital ₹ 2.00 M
as on 26-07-2024
- Company Age 24 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 39.30%
(FY 2023)
- Profit 193.00%
(FY 2023)
- Ebitda 730.93%
(FY 2023)
- Net Worth 1.17%
(FY 2023)
- Total Assets -5.67%
(FY 2023)
About Chandra Ayurved Bhawan
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ajit Parekh and Chandrika Parekh serve as directors at the Company.
- CIN/LLPIN
U99999MH2000PTC129279
- Company No.
129279
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Oct 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Chandra Ayurved Bhawan Private Limited offer?
Chandra Ayurved Bhawan Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Cooking Spices and Masala, Whole Spices, Ayurvedic Powder and Medicinal Herbs, Herbs,Sticks and Roots, Herbal Raw Material, Ayurvedic Digestive Medicine, Ayurvedic Digestive Powder, Citrus Fruits.
Who are the key members and board of directors at Chandra Ayurved Bhawan?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajit Parekh  | Director | 20-Oct-2000 | Current |
| Chandrika Parekh | Director | 20-Oct-2000 | Current |
Financial Performance of Chandra Ayurved Bhawan.
Chandra Ayurved Bhawan Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 39.3% increase. The company also saw a substantial improvement in profitability, with a 193% increase in profit. The company's net worth moved up by a moderate rise of 1.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chandra Ayurved Bhawan?
In 2023, Chandra Ayurved Bhawan had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chandra Ayurved Bhawan?
Unlock and access historical data on people associated with Chandra Ayurved Bhawan, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chandra Ayurved Bhawan, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chandra Ayurved Bhawan's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
